Back to drug list

Fabrazyme (agalsidase beta)


Billing

Code: J0180

Description: Agalsidase beta injection

Unit: 1 mg

Payment: $208.324

Pay quarter: Q1 2023


Medicare history

Dosage and Frequency

Fabry disease

• 1mg/kg IV every 2 weeks

Calculate drug reimbursement


Total Reimbursement:

$17,665.88

(ASP: $16,665.92, Margin: $999.96)


Code:

J0180

# Units to bill:

80

Prior Authorization

Prior auth criteria for Fabrazyme may include but is not limited to:





Insurance prior auth guidelines:


Billable NDCs

58468-0040-01

Fabrazyme (GENZYME CORPORATION)

35 MG


58468-0041-01

Fabrazyme (GENZYME CORPORATION)

5 MG



Resources